Ambrose Bailey

Ambrose Bailey

Chief Executive Officer chez Anterios, Inc.

Fortune : 2 M $ au 31/03/2024

60 ans
Health Technology
Commercial Services
Consumer Services

Profil

Ambrose Robert Douglas Bailey currently works at Anterios, Inc., as Chief Executive Officer, ZELTIQ Aesthetics, Inc., as President & Chief Executive Officer from 2017, Kythera Biopharmaceuticals LLC, as President & Director from 2015, Bausch & Lomb Nordic AB, as Director, Bausch & Lomb BV, as Director, Allergan USA, Inc., as President & Director, Topokine Therapeutics, Inc., as President & Director, U.S.
Chamber Litigation Center, as Director, Convenet Ltd., as Director from 2022, Repros Therapeutics, Inc., as President from 2018, Warner Chilcott Ltd., as Secretary, Vitae Pharmaceuticals LLC, as President from 2016, and Bausch + Lomb Corp., as Chief Legal Officer & Executive Vice President from 2023.
Mr. Bailey also formerly worked at Allergan, Inc., as Chairman, President & Chief Executive Officer, AqueSys, Inc., as Chief Executive Officer, Tobira Therapeutics, Inc., as President, Chief Executive Officer & Director, Allergan GI Corp., as President & Director, Volunteer Legal Services Project of Monroe County, Inc., as Director, TearClear Corp., as Director, Bausch & Lomb, Inc., as Secretary, Executive VP & General Counsel in 2013, Forest Laboratories, Inc., as Secretary, Chief Legal Officer & Senior VP from 2013 to 2014, Goulds Pumps LLC, as Vice President, Bausch & Lomb Holdings, Inc., as Secretary, EVP & General Counsel, Naurex, Inc., as President, Furiex Pharmaceuticals, Inc., as President, Nixon Peabody LLP, as Attorney from 1989 to 1994, Anda, Inc., as President, Durata Therapeutics, Inc., as President, Chief Legal Officer & Secretary, Allergan Ltd.
(Ireland), as Secretary, Chief Legal Officer & EVP from 2014 to 2020, and Forest Laboratories LLC, as President.
Mr. Bailey received his undergraduate degree from St. Olaf College and graduate degree from the University of Minnesota.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
24/04/2024 144 219 ( 0,04% ) 2 M $ 31/03/2024

Postes actifs de Ambrose Bailey

SociétésPosteDébut
KYTHERA BIOPHARMACEUTICALS INC President 01/10/2015
VITAE PHARMACEUTICALS INC President 25/10/2016
ZELTIQ AESTHETICS INC Chief Executive Officer 28/04/2017
REPROS THERAPEUTICS INC President 31/01/2018
BAUSCH + LOMB CORPORATION General Counsel 24/04/2023
Director/Board Member 26/08/2022
Chief Executive Officer -
President -
President -
░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ -
Tous les postes actifs de Ambrose Bailey

Anciens postes connus de Ambrose Bailey

SociétésPosteFin
░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Ambrose Bailey

Formation de Ambrose Bailey

St. Olaf College Undergraduate Degree
University of Minnesota Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Ambrose Bailey

Relations

100 +

Relations au 1er degré

32

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
BAUSCH + LOMB CORPORATION

Health Technology

Entreprise privées29

Health Technology

Health Technology

Health Technology

Producer Manufacturing

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Distribution Services

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Technology Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Ambrose Bailey